2,2'-dipyridyl has been researched along with HIV Coinfection in 10 studies
2,2'-Dipyridyl: A reagent used for the determination of iron.
2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaryal, R | 1 |
| Khan, SA | 1 |
| Li, Z | 1 |
| Li, W | 1 |
| Lu, M | 1 |
| Bess, J | 2 |
| Chao, CW | 1 |
| Gorman, J | 1 |
| Terry, DS | 1 |
| Zhang, B | 1 |
| Zhou, T | 1 |
| Blanchard, SC | 1 |
| Kwong, PD | 1 |
| Lifson, JD | 4 |
| Mothes, W | 1 |
| Liu, J | 1 |
| Miller, E | 1 |
| Spadaccia, M | 1 |
| Sabado, R | 1 |
| Chertova, E | 1 |
| Trubey, CM | 1 |
| Holman, RM | 1 |
| Salazar, A | 1 |
| Lifson, J | 2 |
| Bhardwaj, N | 3 |
| Lubong Sabado, R | 1 |
| Kavanagh, DG | 1 |
| Kaufmann, DE | 1 |
| Fru, K | 1 |
| Babcock, E | 1 |
| Rosenberg, E | 1 |
| Walker, B | 1 |
| Larsson, M | 2 |
| Che, KF | 1 |
| Sabado, RL | 1 |
| Shankar, EM | 1 |
| Tjomsland, V | 1 |
| Messmer, D | 1 |
| Lu, W | 2 |
| Wu, X | 1 |
| Lu, Y | 1 |
| Guo, W | 1 |
| Andrieu, JM | 2 |
| Turville, SG | 1 |
| Santos, JJ | 1 |
| Frank, I | 1 |
| Cameron, PU | 1 |
| Wilkinson, J | 1 |
| Miranda-Saksena, M | 1 |
| Dable, J | 1 |
| Stössel, H | 1 |
| Romani, N | 1 |
| Piatak, M | 1 |
| Pope, M | 1 |
| Cunningham, AL | 1 |
| Fitzgerald, W | 1 |
| Sylwester, AW | 1 |
| Grivel, JC | 1 |
| Margolis, LB | 1 |
| Arraes, LC | 1 |
| Ferreira, WT | 1 |
| Banks, WA | 1 |
| Kumar, VB | 1 |
| Franko, MW | 1 |
| Bess, JW | 1 |
| Arthur, LO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IGHID 1309 -A Phase I Study to Evaluate the Kinetics of the Immunologic Response and Virologic Impact of AGS-004 in HIV-Infected Individuals Suppressed on Antiretroviral Therapy Initiated During Acute and Chronic HIV Infection[NCT02042248] | Phase 1 | 6 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| Phase I/II Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus[NCT02766049] | Phase 1/Phase 2 | 19 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 other studies available for 2,2'-dipyridyl and HIV Coinfection
| Article | Year |
|---|---|
Liquid-assisted mechanochemical synthesis, crystallographic, theoretical and molecular docking study on HIV instasome of novel copper complexes: (µ-acetato)-bis(2,2'-bipyridine)-copper and bromidotetrakis(2-methyl-1H-imidazole)-copper bromide.
Topics: 2,2'-Dipyridyl; Animals; Bromides; Carbon Dioxide; Coordination Complexes; Copper; HIV Infections; H | 2023 |
Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles.
Topics: 2,2'-Dipyridyl; Cell Line; Cryoelectron Microscopy; Disulfides; Electron Microscope Tomography; HIV | 2020 |
Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.
Topics: 2,2'-Dipyridyl; Adaptive Immunity; AIDS Vaccines; beta-Galactosidase; Carboxymethylcellulose Sodium; | 2015 |
In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection.
Topics: 2,2'-Dipyridyl; Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Communication | 2009 |
HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.
Topics: 2,2'-Dipyridyl; Antibodies, Blocking; Antigens, CD; Apoptosis Regulatory Proteins; Cell Communicatio | 2010 |
Therapeutic dendritic-cell vaccine for simian AIDS.
Topics: 2,2'-Dipyridyl; AIDS Vaccines; Animals; Antibodies, Viral; CD4 Lymphocyte Count; CD4-Positive T-Lymp | 2003 |
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.
Topics: 2,2'-Dipyridyl; CD4-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Disulfides; HIV Envelo | 2004 |
Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
Topics: 2,2'-Dipyridyl; B-Lymphocytes; Cells, Cultured; Culture Media, Conditioned; Disulfides; HIV Antibodi | 2004 |
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Topics: 2,2'-Dipyridyl; Adult; AIDS Vaccines; Brazil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes | 2004 |
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Topics: 2,2'-Dipyridyl; Adult; AIDS Vaccines; Brazil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes | 2004 |
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Topics: 2,2'-Dipyridyl; Adult; AIDS Vaccines; Brazil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes | 2004 |
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Topics: 2,2'-Dipyridyl; Adult; AIDS Vaccines; Brazil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes | 2004 |
Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood--brain barrier: comparison of mouse and human brain microvessels.
Topics: 2,2'-Dipyridyl; Animals; Blood-Brain Barrier; Brain; Capillaries; Cell Line; Disulfides; HIV Envelop | 2005 |